Analyst Ratings for NephroGenex, Inc. (NRX)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/8/2016 | H.C. Wainwright | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.50 (0.14) |
-72% | Details |
6/17/2014 | Aegis Capital » Updated 12/31/2014 |
N/A | New Coverage | Buy (N/A) |
15.00 (N/A) |
5.77 (0.14) |
-97.57% | Details |